PIK3CA and glioblastoma: Initially, we examined the effects of the CNS-penetrant selective class I PI3K inhibitor BKM-120 in 3D spheroid invasion assays on a panel of GBM cell lines, including low passage GSCs, neural stem cells and astrocytes (Fig. 1A, Supplementary Fig. 1A).